SBI Securities
CAMP icon

SBI Securities’s CAMP4 Therapeutics CAMP Stock Holding History

SBI Securities’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24 Sell
6
-4
-40% -$16 ﹤0.01% 3888
2026
Q2 		$44 Hold
10
– – ﹤0.01% 3699
2026
Q1 		$44 Hold
10
– – ﹤0.01% 3601
2025
Q4 		$61 Sell
10
-5
-33% -$21 ﹤0.01% 3538
2025
Q3 		$45 Sell
15
-5
-25% -$9 ﹤0.01% 3748
2025
Q2 		$29 Buy
+20
New +$40 ﹤0.01% 3835

Other funds holding CAMP

Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Root Financial Partners
Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

SBI Securities's CAMP Position: Q3 2026 in Review

SBI Securities reduced its CAMP4 Therapeutics (CAMP) stake by 40% in Q3 2026, selling an estimated $16 and leaving 6 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #3888.

SBI Securities first reported a position in CAMP in Q2 2025 and has held it in 6 quarters since. The position peaked at $61 in Q4 2025. 4 funds tracked by Wall St. Rank hold CAMP as of Q3 2026.

  • SBI Securities held 6 shares of CAMP4 Therapeutics worth $24 as of Q3 2026.
  • SBI Securities sold 4 CAMP4 Therapeutics shares in Q3 2026, an estimated $16.
  • CAMP4 Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3888 holding.
  • SBI Securities first reported a position in CAMP4 Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • SBI Securities's CAMP4 Therapeutics position peaked at $61 in Q4 2025.
  • 4 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.